WLM PHARMA
ActiveSummary
WLM PHARMA has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €58,427 and a net result of €27,289. Its solvency ranks better than 16% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.2% (low).
Articles of association
- Name clauseThe name the company operates under according to its articles.
- WLM Pharma
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 2 more provisions in the deed, see the deed of 03-01-2025
Read from the deeds: 3 provisions, deed of 03-01-2025